基于Web of Science的抗菌药物治疗中性粒细胞缺乏伴发热研究热点的可视化分析

Visual analysis of research hotspots on antimicrobial therapy for febrile neutropenia based on Web of Science

  • 摘要:
    目的 对近年来中性粒细胞缺乏伴发热(FN)抗菌治疗相关文献进行计量与可视化分析,探讨该领域研究趋势与热点。
    方法 检索Web of Science数据库,分析文献发表趋势、国家/地区、研究机构、期刊分布、作者影响力及关键词共现情况。利用VOSviewer、Citespace和Scimago Graphica软件进行图谱分析,呈现FN抗菌治疗的研究热点与发展趋势。
    结果 共纳入536篇文献, 2014—2019年的年均发文量约为43篇, 2020—2024年的年均发文量约为54篇,呈上升趋势。发文量最多的国家是美国(134篇,占25.00%); 发文量最多的机构是墨尔本大学(18篇); 发文量最多的作者是GUDIOL C(9篇)。关键词聚类分析显示,研究热点主要集中于“中性粒细胞缺乏伴发热”“抗菌药物管理”“免疫功能受损宿主”“风险评估”“成本效益分析”“经验性治疗”“金黄色葡萄球菌”方面。
    结论 抗菌药物治疗FN相关研究的发文量近年来呈上升趋势,抗菌药物管理、免疫功能受损宿主治疗、耐药性控制及个性化治疗可能成为未来主要研究方向。

     

    Abstract:
    Objective To conduct a bibliometric and visual analysis of literature related to antimicrobial therapy for febrile neutropenia (FN) in recent years and explore the research trends and hotspots in this field.
    Methods The Web of Science database was searched to analyze the publication trends, countries/regions, research institutions, journal distributions, author influences, and keyword co-occurrences. VOSviewer, CiteSpace, and Scimago Graphica software were utilized for mapping analysis to present the research hotspots and development trends of antimicrobial therapy for FN.
    Results A total of 536 articles were included. The average annual number of publications was approximately 43 from 2014 to 2019 and approximately 54 from 2020 to 2024, showing an upward trend. The United States had the highest number of publications (134 articles, accounting for 25.00%). The institution with the most publications was the University of Melbourne (18 articles). The author with the most publications was GUDIOL C (9 articles). Keyword clustering analysis revealed that the research hotspots were mainly concentrated in areas such as "febrile neutropenia", "antimicrobial stewardship", "immunocompromised hosts", "risk assessment", "cost-effectiveness analysis", "empirical therapy" and "Staphylococcus aureus".
    Conclusion The number of publications on research related to antimicrobial therapy for FN has shown an upward trend in recent years. Antimicrobial stewardship, treatment of immunocompromised hosts, control of drug resistance, and personalized therapy may become the main research directions in the future.

     

/

返回文章
返回